Discover
CRVS
Corvus Pharmaceuticals, Inc.
10.52
2 x 10.15
2 x 18.20
bid
ask
+
0.31
3.04%
2 @ 04:01 PM
10.52 +0.00 (0.00%)
| Ytd | 36.62% | |
| 1y | 45.10% |
10.08
day range
10.71
6.50
52 week range
25.52
| Open | 10.21 | Prev Close | 10.21 | Low | 10.08 | High | 10.71 | Mkt Cap | 884.95M |
| Vol | 1.03M | Avg Vol | 986.04K | EPS | -0.64 | P/E | N/A | Forward P/E | -11.75 |
| Beta | 0.86 | Short Ratio | 25.31 | Inst. Own | 85.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 13.28 | 200-d Avg | 14.21 | 1yr Est | 33.14 |
| Income Statement | |||
| Operating Expenses | 19.30M | ||
| Research and Development Expense | 15.96M | ||
| Selling, General and Administrative Expense | 3.33M | ||
| Operating Income | -19.30M | ||
| Net Income | -17.96M | ||
| Net Income Common Stock | -17.96M | ||
| Net Income Common Stock (USD) | -17.96M | ||
| Consolidated Income | -17.96M | ||
| Earnings per Basic Share | -0.19 | ||
| Earnings per Basic Share (USD) | -0.19 | ||
| Earnings per Diluted Share | -0.19 | ||
| Earning Before Interest & Taxes (EBIT) | -17.96M | ||
| Earning Before Interest & Taxes (USD) | -17.96M | ||
| Weighted Average Shares | 92.37M | ||
| Weighted Average Shares Diluted | 92.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.91M | ||
| Cash and Equivalents (USD) | 18.91M | ||
| Investments | 211.43M | ||
| Investments Current | 196.32M | ||
| Investments Non-Current | 15.11M | ||
| Trade and Non-Trade Receivables | 6.00K | ||
| Current Assets | 220.97M | ||
| Property, Plant & Equipment Net | 1.49M | ||
| Total Assets | 239.27M | ||
| Debt Current | 454.00K | ||
| Total Debt | 728.00K | ||
| Current Liabilities | 13.67M | ||
| Debt Non-Current | 274.00K | ||
| Total Liabilities | 13.95M | ||
| Accumulated Retained Earnings (Deficit) | -443.94M | ||
| Accumulated Other Comprehensive Income | -1.29M | ||
| Shareholders Equity | 225.33M | ||
| Shareholders Equity (USD) | 225.33M | ||
| Assets Non-Current | 18.31M | ||
| Total Debt (USD) | 728.00K | ||
| Liabilities Non-Current | 274.00K | ||
| Trade and Non-Trade Payables | 4.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 34.00K | ||
| Net Cash Flow from Financing | 166.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -21.20M | ||
| Capital Expenditure | -582.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.00M | ||
| Issuance (Purchase) of Equity Shares | 166.00K | ||
| Net Cash Flow from Investing | -5.96M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -383.00K | ||
| Net Cash Flow from Operations | -15.40M | ||
| Share Based Compensation | 2.61M | ||